Current status of cell-based interventions in Japan

Cell Stem Cell. 2022 Sep 1;29(9):1294-1297. doi: 10.1016/j.stem.2022.08.003.


The Act on the Safety of Regenerative Medicine regulates cell-based interventions in Japan. Recent revisions to the law require disclosure of explanatory and consent materials for interventions seeking approval. In this Forum, we present an updated analysis of the status and challenges facing the Japanese regulatory framework.

MeSH terms

  • Japan
  • Regenerative Medicine*